Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Regulatory News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £91.78m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

16 Apr 2026 15:00

Faron Pharmaceuticals Ltd | Company announcement | April 16, 2026 at 18:00:00 EEST

FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:Faron Pharmaceuticals Ltd
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuerx
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rightsx
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rightsx
Other (please specify) iii: Dividend payments in kind.
3. Details of person subject to the notification obligation iv
NameTimo Syrj¤l¤
City and country of registered office (if applicable)Monaco
4. Full name of shareholder(s) (if different from 3.) v
NameAcme Investments SPF Sarl
City and country of registered office (if applicable)Luxembourg
5. Date on which the threshold was crossed or reached vi:15.4.2026
6. Date on which issuer notified (DD/MM/YYYY):16.4.2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer (8.A + 8.B) vii
Resulting situation on the date on which threshold was crossed or reached7.77%15.509.433
Position of previous notification (ifapplicable)12.69%14.697.112
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii
A: Voting rights attached to shares
Class/type ofsharesISIN code (if possible)Number of voting rights ix% of voting rights
Direct(DTR5.1)Indirect(DTR5.2.1)Direct(DTR5.1)Indirect(DTR5.2.1)
FI40001533095.949.3209.560.1132.98%4.79%
SUBTOTAL 8. A15.509.4337.77%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrumentExpirationdate xExercise/ Conversion Period xiNumber of voting rights that may be acquired if the instrument isexercised/converted.% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
Type of financial instrumentExpirationdate xExercise/ Conversion Period xiPhysical or cashSettlement xiiNumber of voting rights% of voting rights
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification obligation (please mark theapplicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii
Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xivX
Name xv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Timo Syrj¤l¤ (Direct)2.98%2.98%
Acme Investments SPF Sarl (Indirect)4.79%4.79%
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information Faron share issue during April 2026
Place of completionMonaco
Date of completion16.4.2026
Date   Source Headline
21st Nov 20199:00 amRNSPrice Monitoring Extension
21st Nov 20197:15 amRNSApplication to Nasdaq First North Growth Market
19th Nov 201911:05 amRNSSecond Price Monitoring Extn
19th Nov 201911:00 amRNSPrice Monitoring Extension
15th Nov 201911:06 amRNSSecond Price Monitoring Extn
15th Nov 201911:00 amRNSPrice Monitoring Extension
12th Nov 20193:45 pmRNSRegistration of Shares
8th Nov 20197:00 amRNSResults of Placing and Issue Price
7th Nov 20194:51 pmRNSProposed Placing and Financial Adviser Appointment
5th Nov 20194:40 pmRNSSecond Price Monitoring Extn
5th Nov 20194:36 pmRNSPrice Monitoring Extension
5th Nov 20192:05 pmRNSSecond Price Monitoring Extn
5th Nov 20192:00 pmRNSPrice Monitoring Extension
5th Nov 201911:05 amRNSSecond Price Monitoring Extn
5th Nov 201911:00 amRNSPrice Monitoring Extension
5th Nov 20199:05 amRNSSecond Price Monitoring Extn
5th Nov 20199:00 amRNSPrice Monitoring Extension
4th Nov 20194:35 pmRNSPrice Monitoring Extension
4th Nov 20192:05 pmRNSSecond Price Monitoring Extn
4th Nov 20192:00 pmRNSPrice Monitoring Extension
1st Nov 20192:15 pmRNSStatement regarding Price Movement
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
1st Nov 201911:06 amRNSSecond Price Monitoring Extn
1st Nov 201911:00 amRNSPrice Monitoring Extension
31st Oct 20194:35 pmRNSPrice Monitoring Extension
25th Oct 20199:27 amRNSResults of EGM
11th Oct 20192:05 pmRNSSecond Price Monitoring Extn
11th Oct 20192:00 pmRNSPrice Monitoring Extension
9th Oct 20197:00 amRNSMatins Trial Update
4th Oct 20197:20 amRNSNotice of EGM
2nd Oct 20197:00 amRNSUpdate on Traumakine drug substance manufacturing
30th Sep 20197:00 amRNSMATINS poster presentation at ESMO Congress
25th Sep 20199:13 amRNSHoldings in Company
23rd Sep 20197:08 amRNSInterim results
2nd Sep 20197:00 amRNSMATINS study selected for ESMO 2019
27th Aug 20197:00 amRNSResult of Open Offer and Further Subscription
19th Aug 20199:33 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSNotice of Interim Results
6th Aug 20191:53 pmRNSIssue of Equity
5th Aug 20197:00 amRNSSubscription and Open Offer
12th Jul 20197:00 amRNSMATINS study update
5th Jul 20199:00 amRNSPrice Monitoring Extension
4th Jul 20194:40 pmRNSSecond Price Monitoring Extn
4th Jul 20194:35 pmRNSPrice Monitoring Extension
4th Jul 20192:00 pmRNSPrice Monitoring Extension
4th Jul 20199:31 amRNSHoldings in Company
1st Jul 201912:10 pmRNSGrant of options
26th Jun 20197:00 amRNSPhase II INFORAAA study update
14th Jun 20197:00 amRNSFinal results from YODA study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.